OPKO Health Inc. [NASDAQ: OPK] closed the trading session at $4.27 on 10/22/20. The day’s price range saw the stock hit a low of $4.20, while the highest price level was $4.34. The company report on October 20, 2020 that OPKO Health’s BioReference Laboratories Launches Multiplex COVID-19 and Influenza A/B Test.
New offering identifies COVID-19 and Influenza infections with a single sample.
BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), is now accepting specimens for a new multiplex COVID-19 and influenza test for use by healthcare providers, clinics and health systems throughout the United States, to aid in the diagnosis of COVID-19 and Influenza A or B (flu).
The stocks have a year to date performance of 190.48 percent and weekly performance of 1.18 percent. The stock has been moved at 107.28 percent over the last six months. The stock has performed 40.00 percent around the most recent 30 days and changed -19.43 percent over the most recent 3-months.
If compared to the average trading volume of 14.00M shares, OPK reached to a volume of 5559998 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about OPKO Health Inc. [OPK]:
Piper Jaffray have made an estimate for OPKO Health Inc. shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on November 25, 2019. The new note on the price target was released on March 02, 2018, representing the official price target for OPKO Health Inc. stock. On June 21, 2016, analysts increased their price target for OPK shares from 16 to 18.
The Average True Range (ATR) for OPKO Health Inc. is set at 0.26, with the Price to Sales ratio for OPK stock in the period of the last 12 months amounting to 2.91. The Price to Book ratio for the last quarter was 1.72, with the Price to Cash per share for the same quarter was set at 0.03.
OPK stock trade performance evaluation
OPKO Health Inc. [OPK] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 1.18. With this latest performance, OPK shares gained by 40.00% in over the last four-week period, additionally plugging by 107.28% over the last 6 months – not to mention a rise of 124.74% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for OPK stock in for the last two-week period is set at 53.66, with the RSI for the last a single of trading hit 54.41, and the three-weeks RSI is set at 54.47 for OPKO Health Inc. [OPK]. The present Moving Average for the last 50 days of trading for this stock 3.86, while it was recorded at 4.36 for the last single week of trading, and 2.85 for the last 200 days.
OPKO Health Inc. [OPK]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and OPKO Health Inc. [OPK] shares currently have an operating margin of -21.79 and a Gross Margin at +29.34. OPKO Health Inc.’s Net Margin is presently recorded at -34.92.
Return on Total Capital for OPK is now -9.99, given the latest momentum, and Return on Invested Capital for the company is -16.27. Return on Equity for this stock declined to -18.49, with Return on Assets sitting at -13.23. When it comes to the capital structure of this company, OPKO Health Inc. [OPK] has a Total Debt to Total Equity ratio set at 19.57. Additionally, OPK Total Debt to Total Capital is recorded at 16.37, with Total Debt to Total Assets ending up at 13.68. Long-Term Debt to Equity for the company is recorded at 18.06, with the Long-Term Debt to Total Capital now at 15.10.
Reflecting on the efficiency of the workforce at the company, OPKO Health Inc. [OPK] managed to generate an average of -$51,661 per employee. Receivables Turnover for the company is 5.64 with a Total Asset Turnover recorded at a value of 0.38.OPKO Health Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.00 and a Current Ratio set at 1.30.
Earnings per share (EPS) analysis for OPKO Health Inc. [OPK] stock
With the latest financial reports released by the company, OPKO Health Inc. posted -0.11/share EPS, while the average EPS was predicted by analysts to be reported at -0.09/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -22.20%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for OPK. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for OPKO Health Inc. go to 12.00%.
OPKO Health Inc. [OPK]: Insider Ownership positions
There are presently around $858 million, or 30.70% of OPK stock, in the hands of institutional investors. The top three institutional holders of OPK stocks are: BLACKROCK INC. with ownership of 37,387,415, which is approximately 5.468% of the company’s market cap and around 1.40% of the total institutional ownership; VANGUARD GROUP INC, holding 37,224,760 shares of the stock with an approximate value of $158.95 million in OPK stocks shares; and STATE STREET CORP, currently with $130.06 million in OPK stock with ownership of nearly 65.172% of the company’s market capitalization.
Positions in OPKO Health Inc. stocks held by institutional investors increased at the end of July and at the time of the July reporting period, where 111 institutional holders increased their position in OPKO Health Inc. [NASDAQ:OPK] by around 50,128,868 shares. Additionally, 69 investors decreased positions by around 14,062,214 shares, while 50 investors held positions by with 136,858,141 shares. The mentioned changes placed institutional holdings at 201,049,223 shares, according to the latest SEC report filing. OPK stock had 49 new institutional investments in for a total of 4,549,371 shares, while 24 institutional investors sold positions of 1,889,439 shares during the same period.